$PVCT News Article - Provectus Announces Presentation of Initial Results from Phase 1B Trial of PV-10 in Combination with KEYTRUDA for Treatment of Checkpoint-Refractory Advanced Melanoma at SMR 2019 Congress
https://marketwirenews.com/news-releases/prov...39909.html